racemetirosine has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, S | 1 |
| Ohshima, K | 1 |
| Onai, T | 1 |
| Umahara, M | 1 |
| Kobayashi, S | 1 |
| Ishihara, H | 1 |
1 other study available for racemetirosine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
[A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; | 1990 |